Tommy Thompson

Tommy Thompson was appointed Chairman of the Board of Vector Science & Therapeutics in April 2026, bringing exceptional healthcare policy expertise to the Wisconsin-based biotech company focused on transdermal and localized drug delivery platforms for pain management, regenerative medicine, orthopedics, and cancer applications.

Thompson served as Wisconsin's longest-serving governor from 1987 to 2001, becoming the only person elected to that office four times. He then led the U.S. Department of Health and Human Services under President George W. Bush from 2001 to 2005, where he oversaw Medicare modernization and major healthcare initiatives. During his HHS tenure, Thompson was instrumental in implementing the Medicare Prescription Drug, Improvement, and Modernization Act and played a significant role in bioterrorism preparedness.

Career History

• Chairman of TherapeuticsMD, Inc., a women's healthcare company (2012 to at least 2024)
• Director, United Therapeutics Corporation, a biopharmaceutical company focused on lung disease treatments (2010 onwards)
• Partner, Akin Gump Strauss Hauer & Feld LLP law firm (2005 to January 2012)
• Independent Chairman, Deloitte Center for Health Solutions (2005 to 2009)
• Interim President, University of Wisconsin System (July 2020 to March 2022)
• Chairman, Physicians Realty Trust, a healthcare REIT

Thompson earned a Bachelor's degree in political science in 1963 and a J.D. degree in 1966 from the University of Wisconsin. He is known in his industry for pioneering welfare reform through Wisconsin Works (W-2), a national model for welfare-to-work legislation enacted in 1996, and gained national attention for his leadership on welfare reform, expanded access to health care for low-income people, and education initiatives.

What Thompson could bring to Vector Science and Therapeutics: With his proven track record in navigating complex regulatory environments at both state and federal levels, combined with deep expertise in Medicare and healthcare modernization, Thompson brings invaluable strategic guidance to Vector's efforts to commercialize biomechanical drug delivery platforms. His extensive experience serving on healthcare company boards and his understanding of healthcare policy implementation position him to accelerate Vector's path to market while addressing regulatory and reimbursement challenges inherent in innovative therapeutic delivery technologies.

This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.